294 related articles for article (PubMed ID: 31618686)
1. Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy.
Shaw V; Srivastava S; Srivastava SK
Semin Cancer Biol; 2021 Jan; 68():75-83. PubMed ID: 31618686
[TBL] [Abstract][Full Text] [Related]
2. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
[TBL] [Abstract][Full Text] [Related]
3. Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections.
Heemskerk MT; Korbee CJ; Esselink JJ; Dos Santos CC; van Veen S; Gordijn IF; Vrieling F; Walburg KV; Engele CG; Dijkman K; Wilson L; Verreck FAW; Ottenhoff THM; Haks MC
Sci Rep; 2021 Oct; 11(1):19634. PubMed ID: 34608194
[TBL] [Abstract][Full Text] [Related]
4. Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent.
Tuan NM; Lee CH
Molecules; 2019 Oct; 24(20):. PubMed ID: 31614431
[TBL] [Abstract][Full Text] [Related]
5. Repurposing psychiatric drugs as anti-cancer agents.
Huang J; Zhao D; Liu Z; Liu F
Cancer Lett; 2018 Apr; 419():257-265. PubMed ID: 29414306
[TBL] [Abstract][Full Text] [Related]
6. Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma.
Elmaci I; Altinoz MA
Crit Rev Oncol Hematol; 2018 Aug; 128():96-109. PubMed ID: 29958636
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of drugs as STAT3 inhibitors for cancer therapy.
Thilakasiri PS; Dmello RS; Nero TL; Parker MW; Ernst M; Chand AL
Semin Cancer Biol; 2021 Jan; 68():31-46. PubMed ID: 31711994
[TBL] [Abstract][Full Text] [Related]
8. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics.
Kirtonia A; Gala K; Fernandes SG; Pandya G; Pandey AK; Sethi G; Khattar E; Garg M
Semin Cancer Biol; 2021 Jan; 68():258-278. PubMed ID: 32380233
[TBL] [Abstract][Full Text] [Related]
9. Systematic repurposing screening in xenograft models identifies approved drugs with novel anti-cancer activity.
Roix JJ; Harrison SD; Rainbolt EA; Meshaw KR; McMurry AS; Cheung P; Saha S
PLoS One; 2014; 9(8):e101708. PubMed ID: 25093583
[TBL] [Abstract][Full Text] [Related]
10. TLC differentiation of butyrophenone and diphenylbutylpiperidine compounds from phenothiazine derivatives.
Pluym A
J Pharm Sci; 1979 Aug; 68(8):1050-2. PubMed ID: 480160
[TBL] [Abstract][Full Text] [Related]
11. Drug rechanneling: A novel paradigm for cancer treatment.
Kaushik I; Ramachandran S; Prasad S; Srivastava SK
Semin Cancer Biol; 2021 Jan; 68():279-290. PubMed ID: 32437876
[TBL] [Abstract][Full Text] [Related]
12. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
Kumar S; Chowdhury S; Kumar S
BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
[TBL] [Abstract][Full Text] [Related]
13. Phyotochemical candidates repurposing for cancer therapy and their molecular mechanisms.
Jung JH; Hwang J; Kim JH; Sim DY; Im E; Park JE; Park WY; Shim BS; Kim B; Kim SH
Semin Cancer Biol; 2021 Jan; 68():164-174. PubMed ID: 31883914
[TBL] [Abstract][Full Text] [Related]
14. Blockade of low and high threshold Ca2+ channels by diphenylbutylpiperidine antipsychotics linked to inhibition of prolactin gene expression.
Enyeart JJ; Biagi BA; Day RN; Sheu SS; Maurer RA
J Biol Chem; 1990 Sep; 265(27):16373-9. PubMed ID: 1697857
[TBL] [Abstract][Full Text] [Related]
15. Autophagosome accumulation-mediated ATP energy deprivation induced by penfluridol triggers nonapoptotic cell death of lung cancer via activating unfolded protein response.
Hung WY; Chang JH; Cheng Y; Cheng GZ; Huang HC; Hsiao M; Chung CL; Lee WJ; Chien MH
Cell Death Dis; 2019 Jul; 10(8):538. PubMed ID: 31308361
[TBL] [Abstract][Full Text] [Related]
16. Repurposing drugs in oncology: From candidate selection to clinical adoption.
Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
[TBL] [Abstract][Full Text] [Related]
17. Conformationally constrained butyrophenones with affinity for dopamine (D(1), D(2), D(4)) and serotonin (5-HT(2A), 5-HT(2B), 5-HT(2C)) receptors: synthesis of aminomethylbenzo[b]furanones and their evaluation as antipsychotics.
Raviña E; Casariego I; Masaguer CF; Fontenla JA; Montenegro GY; Rivas ME; Loza MI; Enguix MJ; Villazon M; Cadavid MI; Demontis GC
J Med Chem; 2000 Nov; 43(24):4678-93. PubMed ID: 11101359
[TBL] [Abstract][Full Text] [Related]
18. Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists.
Gould RJ; Murphy KM; Reynolds IJ; Snyder SH
Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5122-5. PubMed ID: 6136040
[TBL] [Abstract][Full Text] [Related]
19. Drug repositioning: Using psychotropic drugs for the treatment of glioma.
You F; Zhang C; Liu X; Ji D; Zhang T; Yu R; Gao S
Cancer Lett; 2022 Feb; 527():140-149. PubMed ID: 34923043
[TBL] [Abstract][Full Text] [Related]
20. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
